Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (101-110 of 551) with videos related to

Pageof 56
Sort By:
Behavioral Medicine (Washington, D.C.)|January 1, 1991
Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancerS M Levy, R B Herberman, M Lippman, et al.
Current Opinion in Oncology|November 4, 1998
Retinoids in the chemoprevention of bladder cancerA L Sabichi, S P Lerner, H B Grossman, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomasS M Lippman, J R Volk, C M Spier, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Cancer Research|January 19, 1999
Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cellsJ L Clifford, D G Menter, M Wang, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1985
Prognostic risk assessment in primary breast cancer by behavioral and immunological parametersS M Levy, R B Herberman, A M Maluish, et al.
Urology|April 11, 2001
Design considerations for efficient prostate cancer chemoprevention trialsJ J Lee, R Lieberman, J A Sloan, et al.
Cancer Research|April 6, 2001
Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cellsV Subbarayan, A L Sabichi, N Llansa, et al.
Cancer|November 1, 1994
Epidemiology, biology, and chemoprevention of aerodigestive cancerS M Lippman, M Spitz, Z Trizna, et al.
Pageof 56

Showing results (101-110 of 551) with videos related to

Sort By:
Pageof 56
Behavioral Medicine (Washington, D.C.)|January 1, 1991
Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancerS M Levy, R B Herberman, M Lippman, et al.
Current Opinion in Oncology|November 4, 1998
Retinoids in the chemoprevention of bladder cancerA L Sabichi, S P Lerner, H B Grossman, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1988
Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomasS M Lippman, J R Volk, C M Spier, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.
Cancer Research|January 19, 1999
Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cellsJ L Clifford, D G Menter, M Wang, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1985
Prognostic risk assessment in primary breast cancer by behavioral and immunological parametersS M Levy, R B Herberman, A M Maluish, et al.
Urology|April 11, 2001
Design considerations for efficient prostate cancer chemoprevention trialsJ J Lee, R Lieberman, J A Sloan, et al.
Cancer Research|April 6, 2001
Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cellsV Subbarayan, A L Sabichi, N Llansa, et al.
Cancer|November 1, 1994
Epidemiology, biology, and chemoprevention of aerodigestive cancerS M Lippman, M Spitz, Z Trizna, et al.
Pageof 56